The Department of Health and Human Services (HHS) said on Monday it had instructed a monkeypox vaccine manufacturer to deliver an additional 36,000 doses this week as part of a drawdown from a U.S. vaccine stockpile. In a statement, HHS said the doses will be added to the existing 36,000 […]
Read More
LISBON, Portugal — An overall ninefold increase in COVID-19 antibody levels can be seen with a longer interval between first and second doses of the Pfizer/BioNTech (BNT162b2) vaccine in people without prior infection, according to data from the UK government’s SIREN (SARS-CoV-2 Immunity and Reinfection Evaluation) study. This interval-dependent antibody […]
Read More
Administering smaller doses of COVID-19 vaccines could be economically viable and could save more lives than either full-dose vaccination or no vaccination in low- and middle-income countries (LMICs)—even with the emergence of new, more highly transmissible variants, according to a cost-effectiveness modeling study. Assuming a vaccine supply shortage, the study estimated […]
Read More
The US Department of Health and Human Services (HHS) has purchased 600 000 treatment courses of bebtelovimab—a monoclonal antibody that research shows effectively treats the SARS-CoV-2 Omicron variant. Omicron is currently responsible for almost all COVID-19 cases in the US, according to an HHS statement. “We want to make sure if an […]
Read More
The FDA today announced its vaccines advisory committee will meet April 6 to discuss the future of COVID-19 booster doses and how to tell if a specific strain of the coronavirus needs its own vaccine. The independent experts on the Vaccines and Related Biological Products Advisory Committee will be joined by representatives […]
Read More